ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith files initial beneficial ownership statement

PUBT · 3d ago
ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith files initial beneficial ownership statement
  • ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith filed an initial Form 3 on Aug. 17, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002149973-26-000002), on August 17, 2026, and is solely responsible for the information contained therein.